Spesolimab

ATC L04AC22 · 8 markets · 20 records

Spesolimab 8 markets · 20 records Forms

US 6 records · 4 strengths

AU 4 records · 4 strengths

  • 150 mginjectionSPEVIGO spesolimab (rch) 150 mg in 1 mL solution for injection pre-filled syringe also in US·TW unknown
  • 300 mginjectionSPEVIGO spesolimab (rch) 150 mg in 1 mL solution for injection pre-filled syringe also in US unknown
  • 450 mginjectionSPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial unknown

Records without a stated strength · 1 SPEVIGO

CA 3 records · 3 strengths

TW 2 records · 2 strengths

Records without a stated strength · 1 Spevigo solution for infusion、希蓓麗活靜脈輸注液

HK 2 records · 1 strengths

    Records without a stated strength · 1 SPEVIGO CONCENTRATE FOR SOLUTION FOR INFUSION 450 MG/7.5 ML、SPEVIGO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/1ML

    GB 1 records · 1 strengths

    • 450 mg/7.5 mLinjectionSpevigo 450mg/7.5ml concentrate for solution for infusion vials also in SG

    SG 1 records · 1 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 SPEVIGO

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.